Ra Capital Management, L.P. Compass Therapeutics, Inc. Transaction History

Ra Capital Management, L.P.

  • $7.17 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.43 - $3.1 $762,129 - $1.65 Million
-532,958 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.25 - $3.5 $1.65 Million - $4.61 Million
-1,316,560 Reduced 71.18%
532,958 $730,000
Q4 2021

Feb 14, 2022
BUY
$2.88 - $3.98 $5.33 Million - $7.36 Million
1,849,518 New
1,849,518 $5.86 Million

Others Institutions Holding CMPX

# of Institutions
79
Shares Held
91.9M
Call Options Held
0
Put Options Held
0
View Full List

About Compass Therapeutics, Inc.

CMPX Quotes by TradingView
  • Ticker CMPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 101,285,000
  • Market Cap $139M
  • Description
  • Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...
More about CMPX
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email